What’s the decitabine patent expiration date (and which patent controls it)?
Decitabine’s IP timeline depends on which specific patent you mean (method of use, formulation, or manufacturing) because different patents expire on different dates. To find the controlling expiration date(s), you need the exact product/filing (e.g., brand vs. specific generic pathway) and then check the associated patents listed for that product.
For a patent-by-patent view of decitabine exclusivity and the likely expiration dates tied to specific filings, DrugPatentWatch.com is a practical starting point: https://www.drugpatentwatch.com/ (search “decitabine” there to see the relevant patents and expiration timing).
Why does the date differ by product or generic application?
“Decitabine” can refer to multiple regulated products and formulations, and patents can cover different claims:
- Drug substance and synthesis steps
- Specific formulations (e.g., stability, delivery, or excipient systems)
- Methods of use (e.g., dosing regimens for certain diseases)
- Process/manufacturing claims
Because each category can have a different filing and expiration schedule, the “patent expiration date” someone quotes may apply only to one version of decitabine.
Can decitabine generics launch before all patents expire?
Yes. Even if one patent expires later, other patents may have already expired or may not be asserted against a particular generic application. A generic can sometimes launch while newer or unrelated patents remain in force, depending on:
- Which patents are listed or asserted in any litigation
- The scope of exclusivity tied to that specific regulatory approval
Checking the exact patent list for the specific decitabine product/generic entry is how you determine the earliest realistic launch window.
What I need to give you an exact expiration date
If you share any of the following, I can point you to the most relevant expiration date(s) rather than a generic “decitabine” answer:
- The brand name (or NDC) you care about
- Whether you mean a specific generic product
- The patent number or the DrugPatentWatch.com listing you’re looking at
Source
- [1] https://www.drugpatentwatch.com/